iAnthus Successful Opening of First Be. Retail Store

Located on Staten Island, this is the Company's third dispensary to open in New York

iAnthus Capital Holdings, Inc, which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce the successful opening of its first Be.retail store located on Staten Island.

Be. Staten Island is located at 338 New Dorp Lane, Staten Island, New York, 10306, and is the only Registered Organization serving Staten Island's population of close to 500,000. Local media coverage of the opening can be seen on Spectrum News NY1: First Medical Dispensary Opens on Staten Island and SILive.com: First Marijuana Dispensary on Staten Island Opens This Week.

A grand opening celebration for Be.Staten Island is scheduled for Thursday, March 26. The free event will allow patients and members of the community to connect with the on-site medical staff and ask questions regarding patient-access and products.

Concurrently, the Company announced it will convert its Citiva Hudson Valley store to the Be.banner effective Friday, March 13. Be. Hudson Valley is located at 1147 Route 9, Wappingers Falls, New York.  For information regarding store hours, promotions and events, please call 212-257-3145, option 3. 

The New York medical market has more than 113,000 registered patients. Currently, there are ten license holders or Registered Organizations in the state, each with the ability to open four dispensing facilities to serve patients. Governor Cuomo has indicated that adult-use legalization is one of his top legislative priorities for 2020 and the Company looks forward to working with the Governor's office in its effort to improve access to safe, legal, and tested cannabis products. 

According to a recent report by the New York City Comptroller, the potential market for adult-use marijuana in New York State is an estimated $3.1 billion annually.

To learn more about iAnthus Capital visit their Company HQ here

Disclaimer: Past performance is not an indicator of future performance.


This could be one of the best investing opportunities of 2020

Legislative changes are blowing through the US, and with it, an ever-increasing number of states legalising cannabis for recreational use.

With the success seen in Illinois, which legalised for adult-use on January 1 and saw products moving off the shelf at an unprecedented rate, this company is primed to take advantage of the booming US recreational market.

They have secured partnerships with the biggest cannabis companies in the US, and their portfolio is second to none.

And with the sector-wide pullback of 2019, this company is now at a bargain-basement price.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Niki Mohazeb
Niki Mohazeb

Niki is a Sydney based writer, with a passion for promoting the health benefits of medicinal cannabis. Niki also enjoys researching and writing about the future of cannabis along with the many other benefits that the plant provides, such as the diverse utilities of hemp.

Leave a Reply

Your email address will not be published. Required fields are marked *